[Validation of a high sensitive troponin 99th percentile obtained in a general hospital]

María Laura Martínez1, Brunella Bianca Bertazzo2, Juan Gonzalez Grima3

  • 1Hospital Privado Universitario de Córdoba. lmartinezbruno@gmail.com.

Insights

The manufacturer's 99th percentile for high sensitivity cardiac Troponin T (hs-cTnT) showed better sensitivity for diagnosing coronary artery disease than a local hospital's percentile. hs-cTnT is crucial for myocardial infarction diagnosis.

Area of Science:

  • Cardiology
  • Clinical Chemistry
  • Diagnostic Medicine

Background:

  • High sensitivity cardiac Troponin T (hs-cTnT) is vital for diagnosing myocardial infarction.
  • Manufacturer-derived 99th percentiles are standard for hs-cTnT interpretation.
  • Local population validation of these cutoffs is essential for accurate diagnosis.

Purpose of the Study:

  • To validate the manufacturer's 99th percentile (99F) for hs-cTnT against a local hospital's 99th percentile (99L).
  • To compare diagnostic performance using coronary angiography as the gold standard.
  • To assess the utility of hs-cTnT in acute coronary syndromes (ACS).

Main Methods:

  • Retrospective analysis of hs-cTnT results from 415 patients with ACS undergoing coronary angiography (2015-2018).
  • Comparison of diagnostic accuracy metrics (sensitivity, specificity, PPV, NPV) between 99F and 99L.
  • Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

  • 99F demonstrated higher sensitivity (83.6%) versus 99L (69.7%) for significant coronary artery disease (stenosis >70%).
  • Specificity was comparable (44.5% for 99F vs. 58.6% for 99L).
  • ROC curve analysis yielded identical results for both cutoffs (0.641).

Conclusions:

  • The manufacturer's 99th percentile (99F) is preferred for hs-cTnT interpretation in ACS due to superior sensitivity.
  • While sensitivity is lower than previously reported, 99F remains a valuable diagnostic tool.
  • Local validation is important, but manufacturer cutoffs offer better diagnostic performance in this cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
95
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
578
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
313
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
355